Literature DB >> 10933257

Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro.

N M Clarke1, J T May1.   

Abstract

Various antimicrobial factors present in human milk were tested for in-vitro antiviral activity against three rhinoviruses (two clinical isolates and rhinovirus 2) and an isolate of cytomegalovirus (CMV) from human milk. These factors included the gangliosides GM1, 2 and 3, sialyl-lactose, chondroitin sulphates A, B and C, prostaglandins E2 and F2alpha, monolaurin, vitamin A and the protein lactoferrin. All were tested for their ability to inhibit growth of the viruses in cell culture. Human milk was also tested for antiviral activity against these viruses. Only vitamin A, monolaurin and lactoferrin inhibited the growth of CMV, whereas both prostaglandins enhanced the growth of this virus at least four-fold. CMV infects infants from milk but, nevertheless, the milk-borne CMV isolate showed no special resistance to any of the antiviral factors tested. None of the compounds inhibited or enhanced the growth of the rhinoviruses. However, human milk decreased the growth of some of the rhinoviruses and specific secretory immunoglobulin A (sIgA) neutralised the virus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933257     DOI: 10.1099/0022-1317-49-8-719

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  19 in total

Review 1.  Cytomegalovirus transmission from breast milk in premature babies: does it matter?

Authors:  P Bryant; C Morley; S Garland; N Curtis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

2.  Human milk glycosaminoglycans inhibit cytomegalovirus and respiratory syncytial virus infectivity by impairing cell binding.

Authors:  Rachele Francese; Manuela Donalisio; Massimo Rittà; Federica Capitani; Veronica Mantovani; Francesca Maccari; Paola Tonetto; Guido E Moro; Enrico Bertino; Nicola Volpi; David Lembo
Journal:  Pediatr Res       Date:  2022-05-05       Impact factor: 3.756

3.  Excretion of Cell-Free and Cell-Associated Zika Virus into Breast Milk of Infected Dams and Identification of Antiviral Factors.

Authors:  Sophie Desgraupes; Patricia Jeannin; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Aurore Vidy
Journal:  Viruses       Date:  2022-04-20       Impact factor: 5.818

4.  Inhibition of In Vitro Infection of Hepatitis B Virus by Human Breastmilk.

Authors:  Yuqian Luo; Kuanhui Xiang; Jingli Liu; Ji Song; Jing Feng; Jie Chen; Yimin Dai; Yali Hu; Hui Zhuang; Yihua Zhou
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

5.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 6.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

7.  Glycerol monolaurate induces filopodia formation by disrupting the association between LAT and SLP-76 microclusters.

Authors:  Michael S Zhang; Phuong M Tran; Alexander J Wolff; Mikaela M Tremblay; Micaela G Fosdick; Jon C D Houtman
Journal:  Sci Signal       Date:  2018-05-01       Impact factor: 8.192

8.  The Clinical Use of Monolaurin as a Dietary Supplement: A Review of the Literature.

Authors:  Lisa A Barker; Barclay W Bakkum; Cynthia Chapman
Journal:  J Chiropr Med       Date:  2020-09-03

9.  Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.

Authors:  Esmail M El-Fakharany; Lourdes Sánchez; Hussein A Al-Mehdar; Elrashdy M Redwan
Journal:  Virol J       Date:  2013-06-19       Impact factor: 4.099

10.  Glycerol Monolaurate (GML) inhibits human T cell signaling and function by disrupting lipid dynamics.

Authors:  Michael S Zhang; Aline Sandouk; Jon C D Houtman
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.